Track Pulmonx's receivables ($11M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Pulmonx (LUNG) currently reports a receivables of $11M as of March 2026. That compares with $15M in the prior-year period — down 25.8% year over year. Use the charts on this page to explore Pulmonx's receivables history and peer comparisons.
Pulmonx's receivables decreased from $15M to $11M — a 25.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Pulmonx reported $11M in receivables as of March 2026. That compares with $15M in the prior-year period — down 25.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pulmonx, and consider following LUNG for alerts when major investors trade the stock.
Pulmonx is classified in the Healthcare sector. On receivables, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LUNG with unrelated industries.